LAKEN ARMSTRONG: Open Payments
NPI 1982275491 · MONTGOMERY, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$430 in 26 payments from 10 companies in 2025. Trend: 2023 $122 · 2024 $507 · 2025 $430
Food & beverage: $430
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 11 | $136 |
| SCPHARMACEUTICALS INC. | 3 | $52 |
| Merck Sharp & Dohme LLC | 3 | $43 |
| Philips North America LLC | 2 | $40 |
| ABIOMED | 1 | $40 |
| Alnylam Pharmaceuticals Inc. | 1 | $31 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $29 |
| E.R. Squibb & Sons, L.L.C. | 2 | $28 |
| PFIZER INC. | 1 | $17 |
| AstraZeneca Pharmaceuticals LP | 1 | $14 |
Products named: LEQVIO, FUROSCIX, VERQUVO, Ambulatory Monitoring & Diagnostics Undivided, AMVUTTRA, Kerendia, CAMZYOS, VYNDAQEL.
Industry payments across AL — which companies pay providers there.
